We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

One Year Later: CRISPR Success in Duchenne Muscular Dystrophy Model

News   Feb 19, 2019 | Original story from Duke University

 
One Year Later: CRISPR Success in Duchenne Muscular Dystrophy Model

These images highlight the stark contrast between mouse models of untreated Duchenne muscular dystrophy (left) and those treated with a CRISPR-based genetic therapy after one year (right). On the right, green indicates a higher level of dystrophin gene expression. The dark spots in the inset show T cells from these mice responding to the bacterial Cas9 protein, indicating the presence of an immune response to the therapy. Credit: Charles Gersbach, Duke University

 
 
 

RELATED ARTICLES

A New Toolkit Can Identify Microbial Communities and Their Functions

News

Study reports a new method of analyzing the codes found in RNA that can delineate human microbial communities and reveal how they operate.

READ MORE

There’s a New Bobtail Squid in Town

News

Researchers have identified a new species of bobtail squid inhabiting Okinawa's waters - dubbed Euprymna brenneri.

READ MORE

A Way To "Fingerprint" Human Cells

News

Researchers have developed a new method to analyse data from individual human cells, which they say could be a step-change for diagnosing some of the most devastating diseases, including cancer and autoimmune disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE